$1.35
1.91% today
Nasdaq, Aug 12, 10:00 pm CET
ISIN
IL0011651580
Symbol
PRFX

PainReform Ltd Stock price

$1.38
-0.01 0.72% 1M
-1.58 53.38% 6M
-1.98 58.87% YTD
-6.22 81.84% 1Y
-190.62 99.28% 3Y
-1,616.22 99.91% 5Y
-1,616.22 99.91% 10Y
-1,616.22 99.91% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
+0.05 3.76%
ISIN
IL0011651580
Symbol
PRFX
Industry

Key metrics

Basic
Market capitalization
$2.8m
Enterprise Value
$-1.5m
Net debt
positive
Cash
$4.3m
Shares outstanding
1.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
0.1
P/B
1.5
Financial Health
Equity Ratio
40.3%
Return on Equity
-799.8%
ROCE
-1,319.8%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-27.6m | -
EBIT
$-27.6m | $-26.3m
Net Income
$-27.4m | $-72.3m
Free Cash Flow
$-12.6m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-188.4% | -
EBIT
-187.9% | -79.5%
Net Income
-193.5% | -395.8%
Free Cash Flow
-88.8%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-60.4
FCF per Share
$-8.6
Short interest
8.9%
Employees
4
Rev per Employee
$0.0
Show more

Is PainReform Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

PainReform Ltd Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a PainReform Ltd forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a PainReform Ltd forecast:

Hold
50%
Sell
50%

Financial data from PainReform Ltd

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 4.47 4.47
26% 26%
-
- Research and Development Expense 23 23
283% 283%
-
-28 -28
188% 188%
-
- Depreciation and Amortization 0.02 0.02
0% 0%
-
EBIT (Operating Income) EBIT -28 -28
188% 188%
-
Net Profit -27 -27
193% 193%
-

In millions USD.

Don't miss a Thing! We will send you all news about PainReform Ltd directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PainReform Ltd Stock News

Neutral
GlobeNewsWire
about one month ago
TEL AVIV, Israel, July 10, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced, through its pharmaceutical division, the signing of a strategic investment agreement with LayerBio Inc., a privately held Boston biotechnology company developing proprietary, long-acting, non-opiate treatments for ophthalmic surgery.
Neutral
PRNewsWire
3 months ago
As a result of increased software sales by the acquirer, and in accordance with the terms of the software business sale agreement, a significant number of zero-exercise-price warrants have matured—Blade Ranger now holds approximately 1 million shares and warrants exercisable at no additional cost TEL AVIV, Israel , May 27, 2025 /PRNewswire/ -- Blade Ranger Ltd. (TASE: BLRN), a company listed on...
Neutral
GlobeNewsWire
3 months ago
TEL AVIV, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX), today announced the launch of a strategic pilot program with Econergy Renewable Energy Ltd., a leading European independent power producer (IPP). The project will utilize PainReform's proprietary DeepSolar™ platform, an AI-powered optimization solution designed to enhance operational efficiency and energy yield a...
More PainReform Ltd News

Company Profile

PainReform Ltd. operates as a pharmaceutical company. It develops and markets pharmaceuticals. The firm focuses on developing reformulation of pain therapeutics, PainReform applies its propriety formulation technologies to prolong and enhance efficacy, reduce adverse effects shortening recovery time and reduce the need of augmentation with drugs such as opioids and NSAIDS. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.

Head office Israel
CEO Ehud Geller
Employees 4
Founded 2007
Website painreform.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today